Home » Activation of p53 in the tumor microenvironment by MDM2 inhibitor APG-115 synergizes with PD-1 blockade independently of p53 status of tumor cells
March 29 to April 3, 2019
Fang DD, Tang Q, Kong Y, et al. Activation of p53 in the tumor microenvironment by MDM2 inhibitor APG-115 synergizes with PD-1 blockade independently of p53 status of tumor cells. Cancer Res 2019;79(13 Suppl). American Association for Cancer Research Annual Meeting 2019. vol. Abstract 3192, View